Busy Philipps says she wasn't supposed to get the scan at all. Her primary care doctor told her in 2025 that she was healthy and didn't need it, but the 47-year-old actress went ahead anyway, and the elective full-body MRI turned up a lesion on her brain that doctors say needed to come out.
Philipps, known for her roles in Cougar Town and Freaks and Geeks, detailed the ordeal in an account reported by FOX 10 Phoenix. Her cousin's husband, Los Angeles internist Dr. Justin Donlan, disagreed with her primary care doctor's recommendation and helped arrange the scan through Prenuvo, according to PopCulture.com. Philipps went forward with the Prenuvo scan despite her own doctor's assurance that it wasn't necessary.
The scan revealed a lesion on her brain, and her results were first evaluated by NYU Langone neurologist Dr. Orrin Devinsky, who happened to already be treating Philipps's 18-year-old daughter Birdie for epilepsy, per the same account from PopCulture.com. Devinsky told Philipps the tumor was inside her brain and needed removal, and the MRI showed a mass that had to come out, according to Devinsky's assessment as relayed in the FOX 10 Phoenix report.
A Five-Hour Surgery and a Rare Diagnosis
That connection put Philipps in touch with Dr. John Golfinos of NYU Langone, and on March 2, 2026, surgeons removed a 2.6-centimeter mass from her brain during a five-hour operation. The mass was diagnosed as a grade 2 oligodendroglioma, a malignant but slow-growing tumor that, per Dr. Alexandra Miller, is considered to have the best prognosis of all malignant gliomas, the FOX 10 Phoenix report notes.
Oligodendroglioma affects an estimated 1,100 to 1,300 people per year in the United States, according to Miller's figures cited in that report. Under the World Health Organization's 2021 classification standards, as explained by the College of American Pathologists, a tumor can only be formally classified as an oligodendroglioma if it shows both an IDH gene mutation and a 1p/19q chromosome co-deletion — the strict genetic fingerprint that separates it from other brain malignancies. A study published in Neuro-Oncology Advances in August 2024 found that patients with grade 2 oligodendroglioma have a median overall survival of roughly 205 months, or more than 17 years, well above the 108-month median for faster-growing grade 3 tumors.
Doctor Says Early Catch Changed the Surgery
Golfinos told Philipps that early detection made her surgery much easier, and that the tumor would have been two or three times larger had it been found later, per his comments in the FOX 10 Phoenix account. Philipps does not need chemotherapy or radiation, though she will receive regular scans going forward to monitor for potential recurrence.
Recovery hasn't been simple. Philipps contracted a staphylococcus infection at her incision site, which was flagged by her dermatologist and required a second operation. That April 2026 procedure was a debridement to clear the infection and remove one of the small titanium tacks implanted in her skull during the original craniotomy, according to an account posted to LiveJournal.
Reflecting on the Tumor's Location and Timing
Philipps's tumor sat in her frontal lobe, and afterward she found herself wondering whether the mass had contributed to unusually intense emotional reactions she'd experienced over the prior two years, the same LiveJournal account states. She has said she learned to trust her instincts through the experience, and has described information as empowering.
The diagnosis arrived in an eerie window of time: James Van Der Beek, her former Dawson's Creek co-star, died after a battle with colorectal cancer the day before Philipps learned she had a brain tumor, according to the FOX 10 Phoenix report. Philipps is currently filming the upcoming legal drama Cupertino, in which she plays the ex-wife of an AI billionaire.
The Bigger Debate Over Elective Body Scans
Philipps's story lands amid a boom in direct-to-consumer whole-body MRI screening. Prenuvo, the company behind her scan, announced in February 2025 that it had quietly raised $120 million in Series B funding in 2024, surpassed 110,000 members, and secured FDA clearance for an AI-powered body composition report, according to a Business Wire release. Out-of-pocket costs for these packages run from roughly $1,000 to nearly $4,000, since routine elective scans for asymptomatic people aren't covered by commercial insurance, as reported by AP News.
Mainstream medical guidance remains skeptical of the practice. The American College of Radiology issued a position statement in April 2023 declaring there is insufficient evidence to justify total body MRI screening for asymptomatic patients without clinical risk factors or family history, warning it can lead to unnecessary follow-up procedures, false positives, and added costs. A lawsuit filed against Prenuvo in September 2024 alleged the company missed clear signs of cerebral artery disease in a 35-year-old patient's $2,500 full-body MRI eight months before that patient suffered a debilitating stroke, according to reporting cited by The Washington Post. Philipps's case, where an elective scan caught a slow-growing but malignant tumor before symptoms progressed, sits squarely at the center of that unresolved tension between individual success stories and broader clinical caution.
-4.webp?w=160&h=400&fit=crop&crop=edges)
